Next Biosciences' partners with Adcock Ingram
By Next Biosciences
16 August 2023
Next Biosciences is thrilled to unveil its strategic partnership with Adcock Ingram as of July 2023, a renowned leader in the eye care field.
Next Biosciences is thrilled to unveil its strategic partnership with Adcock Ingram as of July 2023, a renowned leader in the eye care field.
The first step in developing the most appropriate treatment plan for a patient with dry eye disease (DED) is to correctly categorise the stage and type of DED the patient exhibits using the available technology. Then address the patient’s symptoms using the appropriate evidence-based therapies.
While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.
According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.
Umbilical cord serum contains essential tear components, and umbilical cord serum eyedrops are effective and safe for treating severe dry eye syndrome.
Application of umbilical cord serum eyedrops for the treatment of Neurotrophic Keratitis
To compare the therapeutic effect between autologous serum and umbilical cord serum eye drops in treating severe dry eye syndrome.
Amniotic membrane transplantation may be considered an alternative method for treating persistent epithelial defects and sterile ulceration that are refractory to conventional treatment and before considering treatment by conjunctival flaps or tarsorrhaphy.
Next Biosciences
Ariane Avenue
International Business Gateway
Cnr. New Road and 6th Road
Midrand, South Africa